Figure 5. Expression of AMPKα, p-AMPKα, PPARγ, ACC-α, p-ACC-α, SREBP-2, and HMGR in NAFLD cells.

The NAFLD cells were treated with CHLZT or AICAR. (A) Western blot detection of AMPKα, p-AMPKα, ACC-α, p-ACC-α, PPARγ, and SREBP-2. (B) qRT-PCR detection of PPARγ and SREBP-2. (C) ELISA for HMGR. ***P<0.001.